MA43517A - Vaccin multivalent contre m. hyo et ses utilisations - Google Patents

Vaccin multivalent contre m. hyo et ses utilisations

Info

Publication number
MA43517A
MA43517A MA043517A MA43517A MA43517A MA 43517 A MA43517 A MA 43517A MA 043517 A MA043517 A MA 043517A MA 43517 A MA43517 A MA 43517A MA 43517 A MA43517 A MA 43517A
Authority
MA
Morocco
Prior art keywords
hyo
vaccine against
multivalent vaccine
multivalent
vaccine
Prior art date
Application number
MA043517A
Other languages
English (en)
Inventor
Paulraj Lawrence
Keith Wilson
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MA43517A publication Critical patent/MA43517A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA043517A 2015-12-28 2016-12-14 Vaccin multivalent contre m. hyo et ses utilisations MA43517A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562272017P 2015-12-28 2015-12-28

Publications (1)

Publication Number Publication Date
MA43517A true MA43517A (fr) 2018-11-07

Family

ID=57681803

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043517A MA43517A (fr) 2015-12-28 2016-12-14 Vaccin multivalent contre m. hyo et ses utilisations

Country Status (15)

Country Link
US (2) US20170182141A1 (fr)
EP (1) EP3397279A1 (fr)
JP (1) JP6839714B2 (fr)
KR (1) KR102166196B1 (fr)
CN (1) CN108601824A (fr)
AU (1) AU2016380864B2 (fr)
CA (1) CA3009656A1 (fr)
MA (1) MA43517A (fr)
MX (1) MX2018007950A (fr)
MY (1) MY191905A (fr)
NZ (1) NZ743977A (fr)
PH (1) PH12018501368A1 (fr)
RU (2) RU2018127403A (fr)
SG (1) SG11201805379QA (fr)
WO (1) WO2017116698A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107753942A (zh) * 2017-09-30 2018-03-06 天津瑞普生物技术股份有限公司 一种pcv2、prrsv、猪肺炎支原体三联灭活疫苗制备方法
US11744883B2 (en) 2017-12-22 2023-09-05 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
KR102228308B1 (ko) * 2018-12-19 2021-03-16 주식회사 이노백 마이코플라즈마 폐렴 및 흉막폐렴 예방용 백신 조성물
WO2021018806A1 (fr) * 2019-07-26 2021-02-04 Ceva Sante Animale Sérum porcin appauvri en igg et ses utilisations
KR102646305B1 (ko) * 2021-03-04 2024-03-13 주식회사 이노백 돼지 마이코플라스마균 및 돼지 써코바이러스 감염 예방을 위한 다가 백신 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1991262A4 (fr) * 2006-03-03 2009-11-04 Merial Ltd Vaccin contre le mycoplasma hyopneumoniae
PL2007419T3 (pl) * 2006-04-10 2012-09-28 Intervet Int Bv Szczepionka przeciwko mykoplazmie i PRRSV
CA2710247C (fr) * 2007-12-21 2014-02-18 Wyeth Llc Procedes et compositions pour immuniser des porcs contre le circovirus porcin
KR20100113582A (ko) * 2008-01-23 2010-10-21 베링거잉겔하임베트메디카인코퍼레이티드 Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
AR078253A1 (es) * 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
CA2879228C (fr) * 2012-07-17 2021-07-13 Merial Limited Vaccins attenues de la grippe porcine et procedes de production et d'utilisation associes
CN104043118A (zh) * 2013-03-11 2014-09-17 普莱柯生物工程股份有限公司 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用
WO2014150822A2 (fr) * 2013-03-15 2014-09-25 Boehringer Ingelheim Vetmedica, Inc. Virus, compositions, vaccin et procédés d'utilisation du syndrome dysgénésique et respiratoire porcin

Also Published As

Publication number Publication date
US20240024448A1 (en) 2024-01-25
MY191905A (en) 2022-07-18
WO2017116698A1 (fr) 2017-07-06
JP2019501180A (ja) 2019-01-17
CN108601824A (zh) 2018-09-28
AU2016380864A1 (en) 2018-07-19
RU2021112503A (ru) 2021-05-05
RU2018127403A (ru) 2020-01-30
PH12018501368A1 (en) 2019-02-18
MX2018007950A (es) 2018-09-21
EP3397279A1 (fr) 2018-11-07
JP6839714B2 (ja) 2021-03-10
AU2016380864B2 (en) 2019-10-31
NZ743977A (en) 2020-01-31
US20170182141A1 (en) 2017-06-29
CA3009656A1 (fr) 2017-07-06
KR20180096786A (ko) 2018-08-29
SG11201805379QA (en) 2018-07-30
KR102166196B1 (ko) 2020-10-15
RU2018127403A3 (fr) 2020-01-30

Similar Documents

Publication Publication Date Title
IL261621A (en) Genome edited immune effector cells
EP3411412A4 (fr) Technologie fit-immunoglobuline et ses utilisations
MA46700A (fr) Variants polypeptidiques et ses utilisations
MA43762A (fr) Vaccin contre le rsv
EP3471727A4 (fr) Inhibiteurs de cxcr4 et leurs utilisations
EP3380100A4 (fr) Inhibiteurs de bromodomaines bivalents et leurs utilisations
EP3472129A4 (fr) Inhibiteurs de cxcr4 et leurs utilisations
IL249639A0 (en) Endophytes, associated compositions, and methods of use thereof
EP3334706A4 (fr) Pillararènes et utilisations de ceux-ci
EP3344624A4 (fr) Inhibiteurs de tyk2 et leurs utilisations
EP3236972A4 (fr) N4-hydroxycytidine, ses dérivés et utilisations anti-virales
EP3349802A4 (fr) Dendrimères lipocationiques et leurs utilisations
HUE055473T2 (hu) Difluormetil-aminopiridinek és difluormetil-aminopirimidinek
EP3368546A4 (fr) Conjugués ciblés sstr, et ses particules et formulations
DK3313436T3 (da) Multivalent pneumokok-konjugatvaccine
EP3471726A4 (fr) Inhibiteurs de cxcr4 et leurs utilisations
EP3341007A4 (fr) Inhibiteurs de malt1 et leurs utilisations
EP3347021A4 (fr) Cyano-thiénotriazoloazépines et leurs utilisations
EP3347020A4 (fr) Acétamide thiénotriazoldiazépines et leurs utilisations
IL254412B (en) Prostate antigen standards and uses thereof
MA41022A (fr) Ciblage lysosomial et utilisations correspondantes
EP3361863A4 (fr) Modèle murin de la stéatohépatite non alcoolique et ses utilisations
EP3370771A4 (fr) Conjugués anti-cd3-folate et leurs utilisations
LT3169307T (lt) Vandeninė kompozicija, apimanti paracetamolį ir ibuprofeną
EP3224983C0 (fr) Procédé et dispositif d'authentification